References
- Loudianos G, et al. Wilson's disease. Prilozi 2014;35(1):93–98.
- Pfeiffer RF. Wilson's Disease. Semin Neurol. 2007;27(2): 123–132.
- Harada M. Pathogenesis and management of Wilson disease. Hepatol Res. 2014.
- Brewer GJ. Novel therapeutic approaches to the treatment of Wilson's disease. Expert Opin Pharmacother. 2006;7(3):317–324.
- Amin MA, et al. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg. 2009;33(8):1702–1710.
- Zhu K et al. Partial splenic embolization for hypersplenism in cirrhosis: A long-term outcome in 62 patients. Dig Liver Dis. 2009;41(6):411–416.
- Sternlieb I, Scheinberg IH, and Walshe JM. Bleeding oesophageal varices in patients with Wilson's disease. Lancet 1970;1(7648):638–641.
- Abdella HM, et al. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia. Indian J Gastroenterol. 2010;29(2):59–61.
- Alzen G, et al. Partial splenic embolization as an alternative to splenectomy in hypersplenism–single center experience in 16 years. Klin Padiatr. 2010;222(6):368–373.
- Yoshida H, et al. Partial splenic embolization. Hepatol Res. 2008;38(3):225–233.
- Madoff DC, et al. Splenic arterial interventions: Anatomy, indications, technical considerations, and potential complications. Radiographics 2005;25(Suppl 1):S191–S211.
- Koconis KG, Singh H, and Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: A review of the English language literature. J Vasc Interv Radiol. 2007;18(4):463–481.
- Murata K, et al. Splenectomy improves liver function in patients with liver cirrhosis. Hepatogastroenterology 2008;55(85):1407–1411.
- Smith M, Ray C.E. Splenic artery embolization as an adjunctive procedure for portal hypertension. Semin Intervent Radiol. 2012;29(2):135–139.
- Tokgoz O, et al. Infraclavicular brachial plexus block in Wilson's disease. Middle East J Anesthesiol. 2013;22(1):103–106.
- Baykal M, Karapolat S. Anesthetic management of a pediatric patient with wilsons disease. J Clin Med Res. 2010;2(2):99–101.
- Bo W, et al. Laparoscopy splenectomy for massive splenomegaly. J Invest Surg. 2013;26(3):154–157.
- Gu JJ, et al. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis. Acta Radiol. 2012;53(8):862–867.
- Kim B, Chung SJ, and Shin HW. Trientine-induced neurological deterioration in a patient with Wilson's disease. J Clin Neurosci. 2013;20(4):606–608.
- Kim YE, et al. Unusual epileptic deterioration and extensive white matter lesion during treatment in Wilson's disease. BMC Neurol. 2013;13:127.
- Kalita J, et al. Worsening of Wilson disease following penicillamine therapy. Eur Neurol. 2014;71(3,4):126–31.
- Lang CJ, et al. Fatal deterioration of Wilson's disease after institution of oral zinc therapy. Arch Neurol. 1993;50(10):1007–1008.
- Choi BS, Zheng W. Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res. 2009;1248:14–21.
- Monnot AD, et al. Regulation of brain copper homeostasis by the brain barrier systems: effects of Fe-overload and Fe-deficiency. Toxicol Appl Pharmacol. 2011;256(3): 249–257.
- Stuerenburg HJ. CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease. J Neural Transm. 2000;107(3):321–329.
- Li WJ, Wang JF, Wang XP. Wilson's disease: update on integrated Chinese and Western medicine. Chin J Integr Med. 2013;19(3): 233–240.
- Aggarwal A, Bhatt M. Update on Wilson disease. Int Rev Neurobiol. 2013;110:313–348.
- Dalvi A, Padmanaban M. Wilson's disease: etiology, diagnosis, and treatment. Dis Mon. 2014;60(9):450–459.